Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:59 PM
Ignite Modification Date:
2025-12-24 @ 10:59 PM
NCT ID:
NCT00407069
Eligibility Criteria:
Inclusion Criteria for Participants With AD:
* 2 years of age or older
* History of active or inactive AD OR eczema herpeticum, as defined by the ADVN standardized diagnostic criteria
* Parent or guardian willing to provide informed consent, if applicable
* Male or female of any race and ethnicity
Inclusion Criteria for Participants With Asthma or Psoriasis, and for non-atopic controls:
* 18 years or older
* History of psoriasis OR history of asthma not requiring systemic medications
* Parent or guardian willing to provide informed consent, if applicable
* Male or female of any race and ethnicity
Exclusion Criteria:
* Oral corticosteroids or any systemic immunosuppressive or immunomodulatory medication within 28 days prior to study entry
* Immunotherapy within 3 months prior to study entry
* History of bleeding disorder
* Aspirin, oral antihistamines, oral antibiotics, oral cyclosporine, or topical medications within 7 days of screening visit including, but not restricted to, Protopic, Elidel, topical corticosteroids, and topical antibiotics
* Anxiolytic agents and antidepressants within 2 days of screening visit
* Diabetic requiring medication
* Autoimmune or immunodeficiency
* Active fungal, bacterial, or viral infections within 7 days prior to study entry
* Active systemic cancer. Participants with uncomplicated nonmelanoma skin cancer are not excluded.
* Theophylline or leukotriene antagonists within 24 hours of screening visit
* Received any vaccination within 30 days prior to study entry
* Known lidocaine allergy
* Previously vaccinated for smallpox
* Pregnant or breastfeeding
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
2 Years
Study:
NCT00407069
Study Brief:
Protocol Section:
NCT00407069